Jump to main content
Jump to site search


The in silico and in vivo evaluation of puerarin against Alzheimer’s disease

Abstract

The root of Pueraria lobata has been utilized as a food source for thousands of years in China. Puerarin is the major bioactive and the most abundant secondary metabolite from the root of P. lobate. The potential therapeutic effect of puerarin against Alzheimers was screened by in silico method and confirmed by the amyloid β-peptide-induced Alzheimer’s disease (AD) rats’ model. The in silico study displayed that puerarin had the potential to penetrate across the blood-brain barrier and had high stability in the molecular docking and dynamics simulation with acetylcholinesterase (AChE), cyclooxygenase-2 (COX-2) and caspase-3 (C3), which play a central role in the development of AD. The in vivo results showed that puerarin could restrain the AChE activity, restore the activities of antioxidant defense substances toward normal levels, decrease the expression of inflammatory factors and apoptosis genes in the brain, especially down-regulated the expressions of COX-2 and C3. The histopathological examination of brain sections and behavioral testing also verified the biochemical observations, which further validates the in silico study. These results not only suggest that puerarin, as a potential compound, could relieve AD, but also broaden the applications of puerarin.

Back to tab navigation

Publication details

The article was received on 27 Aug 2018, accepted on 07 Jan 2019 and first published on 08 Jan 2019


Article type: Paper
DOI: 10.1039/C8FO01696H
Citation: Food Funct., 2019, Accepted Manuscript
  •   Request permissions

    The in silico and in vivo evaluation of puerarin against Alzheimer’s disease

    S. Liu, X. Cao, G. Liu, T. Zhou, X. Yang and B. Ma, Food Funct., 2019, Accepted Manuscript , DOI: 10.1039/C8FO01696H

Search articles by author

Spotlight

Advertisements